Clinical trial NCT02644044 - References

To Evaluate the Effect of Therapy With IT MTX on the Disease Course of Patients With Progressive MS — Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

Citation(s)

•   American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines
  Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum. 2002 Feb;46(2):328-46.
•   Ashtari F, Savoj MR
  Effects of low dose methotrexate on relapsing-remitting multiple sclerosis in comparison to Interferon ß-1a: A randomized controlled trial. J Res Med Sci. 2011 Apr;16(4):457-62.
•   Currier RD, Haerer AF, Meydrech EF
  Low dose oral methotrexate treatment of multiple sclerosis: a pilot study. J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1217-8. Erratum in: J Neurol Neurosurg Psychiatry 1994 Apr;57(4):528.
•   Goodkin DE, Rudick RA, VanderBrug Medendorp S, Daughtry MM, Schwetz KM, Fischer J, Van Dyke C
  Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis. Ann Neurol. 1995 Jan;37(1):30-40.
•   Hartung HP, Gonsette R, König N, Kwiecinski H, Guseo A, Morrissey SP, Krapf H, Zwingers T; Mitoxantrone in Multiple Sclerosis Study Group (MIMS)
  Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial. Lancet. 2002 Dec 21-28;360(9350):2018-25.
•   Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, Reynolds R, Aloisi F
  Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007 Apr;130(Pt 4):1089-104.
•   Sadiq SA (2005) Multiple sclerosis
  In: Rowland LP (ed) Merritt's neurology, 11th edn. Lippincott Williams and Wilkins, Philadelphia, pp 941-963
•   Sadiq SA, Simon EV, Puccio LM
  Intrathecal methotrexate treatment in multiple sclerosis. J Neurol. 2010 Nov;257(11):1806-11. doi: 10.1007/s00415-010-5614-4. Epub 2010 Jun 10.
•   Siegal T, Lossos A, Pfeffer MR
  Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology. 1994 Aug;44(8):1463-9.

Intrathecal Methotrexate for Progressive Multiple Sclerosis: An Open Label Single Arm Study

Details for clinical trial NCT02644044